Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jan;19(1):138-41.
doi: 10.1007/BF02872409.

Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis

Affiliations

Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis

Soma Gupta et al. Indian J Clin Biochem. 2004 Jan.

Abstract

Lipid peroxidation product, malonaldehyde (MDA) and antioxidants were estimated in plasma and erythrocytes of 34 cases of oral submucous fibrosis (OSMF) of different grades with equal number of healthy controls to evaluate the association of reactive oxygen species (ROS) and OSMF. While plasma MDA was found to be significantly higher in patients (3.3±0.4 nmole/ml, P<0.001) as compared to controls (2.4±0.5 nmole/ml), plasma beta carotene and vitamin E levels were found to be decreased significantly in patients (81.7±14.3 μg/100 ml, P<0.001; 9.3±0.9 mg/L, P<0.01 respectively) with respect to healthy controls (110±20.8 μg/100 ml and 10.1±1.2 mg/L). The decrease in beta-carotene and vitamin E was found to be more significant in OSMF grade II and III than in grade I. After 6 weeks of oral administration of beta-carotene and vitamin E, patients showed increase in plasma level of these two antioxidants along with decrease in MDA level associated with clinical improvement.

Keywords: Beta-carotene; MDA; OSMF; ROS; Vitamin E.

PubMed Disclaimer

References

    1. Gupta P.C., Sinor P.N., Bhonsle R.B., Pawar V.S., Mehta H.C. Oral submucous fibrosis in India, A new epidemic? Natl. Med. J. India. 1998;11:113–116. - PubMed
    1. Pindborg J.J. Oral submucous fibrosis as a precancerous condition. Scand. J. Dent. Res. 1984;92:224–229. - PubMed
    1. Gupta P.C., Bhosle R.B., Murti P.R., Daftary D.K., Mehta F.S., Pindborg J.J. An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special references to nodular lenkoplakia. Cancer. 1989;63:2247–2252. doi: 10.1002/1097-0142(19890601)63:11<2247::AID-CNCR2820631132>3.0.CO;2-D. - DOI - PubMed
    1. Rajendran R. Oral submucous fibrosis: Etiology, pathogenesis and future research. Bull. WHO. 1994;72:985–986. - PMC - PubMed
    1. Pindborg J.J. Oral submucous fibrosis: A review. Ann. Acad. Med. 1989;18:603–607. - PubMed

LinkOut - more resources